Dorzolamide/Timolol Fixed Combination Versus Concomitant Administration of Brimonidine and Timolol in Patients with Elevated Intraocular Pressure: A 3-Month Comparison of Efficacy, Tolerability, and Patient-Reported Measures

Journal of Glaucoma

Volumn 13, Issue 2, 2004, Pages 149-157

  Solish, Alfred M ^a   DeLucca, Paul T ^b   Cassel, Deborah A ^b   Kolodny, Andrea H ^b   Hustad, Carolyn M ^b   Skobieranda, Franck ^b  

^a Southern California Glaucoma Consultants   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Brimonidine; Dorzolamide; Elevated IOP; Glaucoma

Indexed keywords

BRIMONIDINE; DORZOLAMIDE PLUS TIMOLOL; TIMOLOL;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG MIXTURE; DRUG SAFETY; DYSPNEA; FEMALE; GLAUCOMA; HUMAN; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OPEN ANGLE GLAUCOMA; PATIENT SATISFACTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SINGLE BLIND PROCEDURE;

ADULT; AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; OCULAR HYPERTENSION; OPHTHALMIC SOLUTIONS; PATIENT SATISFACTION; PROSPECTIVE STUDIES; QUINOXALINES; SAFETY; SULFONAMIDES; THIOPHENES; TIMOLOL; TREATMENT OUTCOME;

EID: 1642360965     PISSN: 10570829     EISSN: None     Source Type: Journal    
DOI: 10.1097/00061198-200404000-00012     Document Type: Article

References (8)

1. Alward WL. Medical management of glaucoma. N Engl J Med. 1998;339: 1298-1307.
2. Strohmaier K, Snyder E, DuBiner H, et al. The efficacy and safety of the dorzolamide-timolol combination versus the concomitant administration of its components. Ophthalmology. 1998;105:1936-1944.
3. Boyle JE, Ghosh K, Gieser DK, et al. A randomized trial comparing the dorzolamide-timolol combination given twice daily to monotherapy with timolol and dorzolamide. Ophthalmology. 1998;105:1945-1951.
4. Clineschmidt CM, Williams RD, Snyder E, et al. A randomized trial in patients inadequately controlled with timolol alone comparing the dorzolamide-timolol combination to monotherapy with timolol or dorzolamide. Ophthalmology. 1998;105:1952-1959.
5. Stewart WC, Sharpe ED, Harbin TS, et al. Brimonidine 0.2% versus dorzolamide 2% each given three times daily to reduce intraocular pressure. Am J Ophthalmol. 2000;129:723-727.
6. Simmons ST. Efficacy of brimonidine 0.2% and dorzolamide 2% as adjunctive therapy to beta-blockers in adult patients with glaucoma or ocular hypertension. Clin Ther. 2001;23:604-619.
7. Centofanti M, Manni G, Gregori D, et al. Comparative acute effects of brimonidine 0.2% versus dorzolamide 2% combined with beta-blockers in glaucoma. Graefes Arch Clin Exp Ophthalmol. 2000;238:302-305.
8. Sall KN, Greff LJ, Johnson-Pratt LR, et al. Dorzolamide/timolol combination versus concomitant administration of brimonidine and timolol: Six-month comparison of efficacy and tolerability. Ophthalmology. 2003; 110:615-624.